Search Results - Nodzon, Lisa, ARNP

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia

    Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia by Chavez, Julio C., MD, Piris-Villaespesa, Miguel, MD, Dalia, Samir, MD, Powers, John, PhD, Turba, Elyce, RN, Nodzon, Lisa, ARNP, Komrokji, Rami, MD, Sokol, Lubomir, PhD, Locke, Frederick L., MD, Lancet, Jeffrey, MD, Sotomayor, Eduardo M., MD, Kharfan-Dabaja, Mohamed A., MD, Pinilla-Ibarz, Javier, MD, PhD

    Published in Leukemia research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Therapeutic Updates for Richter Syndrome: Highlights From SOHO 2021

    Therapeutic Updates for Richter Syndrome: Highlights From SOHO 2021 by Nodzon, PhD, ARNP, AOCNP, Lisa

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Updates on Clinical Trials for Myelofibrosis: Highlights From SOHO 2021

    Updates on Clinical Trials for Myelofibrosis: Highlights From SOHO 2021 by Nodzon, PhD, ARNP, AOCNP, Lisa

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    BCMA-Directed CAR T Cells in Relapsed Refractory Multiple Myeloma: Highlights From SOHO 2021

    BCMA-Directed CAR T Cells in Relapsed Refractory Multiple Myeloma: Highlights From SOHO 2021 by Nodzon, PhD, ARNP, AOCNP, Lisa

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Updates on Therapeutic Advancements in Relapsed or Refractory Multiple Myeloma: Highlights From SOHO 2020

    Updates on Therapeutic Advancements in Relapsed or Refractory Multiple Myeloma: Highlights From SOHO 2020 by Nodzon, PhD, ARNP, AOCNP, Lisa

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Emerging Therapies in Myelofibrosis: Highlights From SOHO 2020

    Emerging Therapies in Myelofibrosis: Highlights From SOHO 2020 by Nodzon, PhD, ARNP, AOCNP, Lisa

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Minimal Residual Disease in Chronic Lymphocytic Leukemia: Highlights From SOHO 2020

    Minimal Residual Disease in Chronic Lymphocytic Leukemia: Highlights From SOHO 2020 by Nodzon, PhD, ARNP, AOCNP, Lisa

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Cardiovascular Adverse Events and Mitigation Strategies for Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy

    Cardiovascular Adverse Events and Mitigation Strategies for Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy by Nodzon, Lisa, Fadol, Anecita, Tinsley, Sara

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Risk-Adapted Treatment Strategies for Chronic Lymphocytic Leukemia

    Risk-Adapted Treatment Strategies for Chronic Lymphocytic Leukemia by Nodzon, PhD, ARNP, AOCNP, Lisa, Pinilla-Ibarz, MD, PhD, Javier

    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Bosutinib Therapy in Patients With Chronic Myeloid Leukemia: Practical Considerations for Management of Side Effects

    Bosutinib Therapy in Patients With Chronic Myeloid Leukemia: Practical Considerations for Management of Side Effects by Ault, Patricia S, Rose PharmD, John, Nodzon PhD, Lisa A, Kaled, Elizabeth S

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: